Smith Salley Wealth Management - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
Smith Salley Wealth Management ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$16,506
+27.0%
12,0480.0%0.00%0.0%
Q3 2022$13,0000.0%12,0480.0%0.00%0.0%
Q2 2022$13,0000.0%12,0480.0%0.00%0.0%
Q1 2022$13,00012,0480.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Orin Green Financial, LLC 80,000$132,8000.07%
GSA CAPITAL PARTNERS LLP 496,781$8250.07%
DENALI ADVISORS LLC 110,200$182,9320.06%
XTX Topco Ltd 83,973$139,3950.02%
CAPITAL PERFORMANCE ADVISORS LLP 25,974$43,1170.02%
State of Wyoming 41,268$68,5050.02%
HARBOUR INVESTMENT MANAGEMENT LLC 10,100$16,7660.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 158,790$263,5910.01%
Truvestments Capital LLC 3,880$6,4410.00%
Renaissance Technologies 621,100$1,0310.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders